Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics
Journal of Experimental Neuroscience · 2019-01 · 13
DOI: 10.1177/1179069519862798 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Experimental Neuroscience, online erschienen am 10.07.2019. Verfasst von Michelle E Watts und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS), the most common motor neuron (MN) disease of adults, is characterized by the degeneration of upper MNs in the motor cortex and lower MNs in the brain stem and spinal cord. Our recent work suggests that a MAP kinase family member, MAP4K4 (mitogen-activated protein kinase kinase kinase kinase 4), regulates MN degeneration in ALS. Activation of MAP4K4 occurs prior to MN death and inhibition of MAP4K4 improves neurite integrity and neuronal viability in a cell autonomous manner. The mechanism through which MAP4K4 reduction specifically modulates MN viability can be attributed to the attenuation of the c-Jun apoptotic pathway, as well as to the activation of FoxO1-mediated autophagy that reduces the accumulation of protein aggregates. We additionally show the feasibility of MAP4K4 as a drug target using a MAP4K4-specific inhibitor, which improves the survival of both primary and induced pluripotent stem cell (iPSC)-derived MNs. Our studies are thus far the first to highlight a MAP4K4-initiated signaling cascade that contributes to MN degeneration in ALS, providing a new mechanism underlying MN death in disease and a druggable target for new therapeutics. We propose exciting future directions and unexplored avenues based upon this work.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
ORCID-Profile: Michelle E Watts
Zitieren
APA
Watts, M. E., Wu, C., & Rubin, L. L. (2019). Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics. Journal of Experimental Neuroscience, 13. https://doi.org/10.1177/1179069519862798
Vancouver
Watts ME, Wu C, Rubin LL. Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics. Journal of Experimental Neuroscience. 2019;13. doi:10.1177/1179069519862798
BibTeX
@article{Watts2019,
author = {Watts, Michelle E and Wu, Chen and Rubin, Lee L},
title = {Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics},
journal = {Journal of Experimental Neuroscience},
year = {2019},
volume = {13},
doi = {10.1177/1179069519862798}
}
EUVIMED